Manhattan Pharmaceuticals to Ring Opening Bell at American Stock Exchange
Jun 07, 2006
NEW YORK, NY JUNE 7 - Manhattan Pharmaceuticals, Inc. (AMEX: MHA) today announced that Douglas Abel, president and chief executive officer, will ring the opening bell at the American Stock Exchange (Amex) on Friday, June 9, 2006 at 9:30am EDT. On hand for the bell ringing ceremony will be members of Mr. Abel's management team, including Nicholas J. Rossettos, Chief Financial Officer, Dr. Alan G. Harris, Chief Medical Officer, and Dr. Bina Tejura, Assistant Chief Medical Officer. Manhattan Pharmaceuticals began trading on the Amex under the symbol MHA on October 7, 2005.
"We believe our listing on the Amex has afforded Manhattan Pharmaceuticals great visibility and it supports our vision of future growth for the company," Mr. Abel said. "It is an honor to be part of the American Stock Exchange and to participate in this great tradition."
About Manhattan Pharmaceuticals, Inc.
Manhattan Pharmaceuticals, Inc., a development-stage pharmaceutical company, acquires and develops proprietary prescription drugs for large, underserved patient populations. In view of the worldwide obesity epidemic, the company is developing OE, an orally administered novel therapeutic for the treatment of obesity. To meet the needs of other major, underserved medical markets while lowering development risks, Manhattan Pharmaceuticals is also developing PTH (1-34), a peptide believed to be a regulator of epidermal cell growth, for psoriasis, and Propofol Lingual Spray, a convenient, proprietary lingual spray formulation of propofol, the world's best-selling general anesthetic, as a sedative-hypnotic for use during diagnostic and therapeutic procedures. (http://www.manhattanpharma.com)